---
title: "BRANDMAX: Zeng Jun completed a reduction of 1.00%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/256751563.md"
description: "BRANDMAX announced that shareholder Zeng Jun holds 13.4715 million shares, accounting for 3.18%. Previously, he planned to reduce his holdings by no more than 4.2425 million shares, accounting for 1.00%, through block trading within three months after the self-disclosure of 15 trading days. On September 10, 2025, Zeng Jun cumulatively reduced his holdings by 4.2425 million shares at an average price of 10.41 yuan per share through block trading, accounting for 1.00%. The plan has been completed, and after the reduction, he holds 9.229 million shares, accounting for 2.18%"
datetime: "2025-09-10T12:40:32.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/256751563.md)
  - [en](https://longbridge.com/en/news/256751563.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/256751563.md)
generator: "portal-rs"
---

# BRANDMAX: Zeng Jun completed a reduction of 1.00%

BRANDMAX announced that shareholder Zeng Jun holds 13.4715 million shares, accounting for 3.18%. Previously, he planned to reduce his holdings by no more than 4.2425 million shares, accounting for 1.00%, through block trading within three months after the pre-disclosure of 15 trading days. On September 10, 2025, Zeng Jun cumulatively reduced his holdings by 4.2425 million shares through block trading at an average price of 10.41 yuan per share, accounting for 1.00%. The plan has been completed, and after the reduction, he holds 9.229 million shares, accounting for 2.18%

### Related Stocks

- [300805.CN](https://longbridge.com/en/quote/300805.CN.md)

## Related News & Research

- [22:00 ETCarestream Healthcare International améliore le détecteur DRX-LC pour améliorer les performances d'imagerie de grande longueur](https://longbridge.com/en/news/297978656.md)
- [10:17 ETDarkforce™ advances toward FedRAMP High for government deployment](https://longbridge.com/en/news/297666526.md)
- [CVC Strategic Opportunities makes first outside equity investment in Unitex alongside Potack family](https://longbridge.com/en/news/297911948.md)
- [Egetis says new Emcitate clinical data from Triac Trial II, ReTRIACt to be presented at September congresses](https://longbridge.com/en/news/297996002.md)
- [Adamera Defines IP Anomaly with Minimum Width of 2.8km at Max Copper-Gold Target, South Hedley Project, BC, IP Program Resumes as Wildfire Risks Ease](https://longbridge.com/en/news/297778308.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**